MeMed has developed MeMed BV Flex, a rapid infection differentiation test that distinguishes between bacterial and viral infections.

Edwards Lifesciences has lifted its 2025 profit outlook to between 9%-10%, up from 8%-10%, amid strong Q2 2025 performance in its Transcatheter Aortic Valve Replacement (TAVR) and Transcatheter Mitral ...

The US Food and Drug Administration (FDA) has approved an improved stool collection kit of Geneoscopy’s CRC screening test, ColoSense.

The UK and India’s new £4.8bn free trade agreement (FTA) is expected to allow new opportunities for Indian medical device and pharmaceutical manufacturers.

The Advanced Medical Technology Association (AdvaMed) has expressed support for the Trump administration’s artificial intelligence (AI) action plan.

The FDA has granted 510(k) clearance for Philips’ latest UroNav version, an advancement in image-guided navigation for prostate cancer care.

Following a period of relative dormancy, research and development in the Alzheimer’s disease space is booming. And mounting attention, both in the development of disease modifying therapies (DMTs) and ...

Becton, Dickinson and Company (BD) has announced a trial utilising the BD Libertas Wearable Injector for subcutaneous delivery of biologics.

Roche’s Elecsys pTau181 test has secured CE Mark approval, marking a development in ruling out Alzheimer's disease.

Nestmedic has chosen Curavit Clinical Research to spearhead the US clinical study of the remote prenatal monitoring solution, PregnaOne.

RadNet's subsidiary DeepHealth has concluded the previously announced acquisition of iCAD in a deal valued at $103m.

Charlie Whelan, a Senior Director of Consulting at GlobalData, discusses the latest trends in medical devices for 2025.